Medpace Holdings, Inc. Logo

Medpace Holdings, Inc. (1MEDP)

MTA

Currency in EUR
523.80
-4.80 (-0.91%)

Closed

Aug 25, 2026

Day's Range

523.80
531.00

52 wk Range

327.60
554.20

Overview - 1MEDP - Medpace Holdings, Inc.

Key Statistics

Valuation

Enterprise Value

12.39B

P/E (Trailing)

‪36.57‬

PEG Ratio

‪1.00‬

Price / Sales (TTM)

‪5.34‬

Price / Book

‪40.03‬

EV / EBITDA

‪23.73‬

Profitability

Gross Margin

‪28.50%‬

Profit Margin

‪17.66%‬

Operating Margin

‪20.75%‬

Return on Assets

‪20.09%‬

Return on Equity

‪162.15%‬

Ownership

Shares Outstanding

27.91M

Float

22.39M

Held by Insiders

‪19.70%‬

Held by Institutions

‪91.51%‬

Price stats

Beta

‪1.15‬

50-Day Avg

‪453.28‬

200-Day Avg

‪445.35‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 1MEDP - Medpace Holdings, Inc.

Peers - 1MEDP - Medpace Holdings, Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on MTA.

Profile Summary - 1MEDP - Medpace Holdings, Inc.

About

Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV,…

SectorHealthcare
IndustryDiagnostics & Research
Employees6.20K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.